Sentences with phrase «over year dividend»

Not exact matches

Combine that with a sparkling balance sheet and its history of never cutting its dividend — the yield is now 2.5 % — and its beaten - down share price (down by a third over the past two years) looks like an opportunity to pick up a high - quality bargain.

That operating wizardry has allowed the sports - apparel Goliath to push its dividend up steadily, at 18 % a year over the past decade, an «astonishingly good number,» says Kilbride.

The big - box chain has a yield in line with its frugal prices — a bargain - basement 1.2 % — but that dividend has been rising 24 % a year over the past 10 years.

This Toronto - based property and casualty insurance company has increased its dividend by more than 50 % over the past three years while its stock price has climbed from $ 35 to $ 62.

With this Armonk, N.Y. — based technology giant, you're getting a company that's increased its dividend for 18 straight years and has a proven that it can grow its earnings over the long term.

I am pleased to announce that our Board of Directors declared a 7 % increase in our quarterly cash dividend to $ 0.77 per share, marking 14 consecutive years of dividend increases with a compound annual growth rate of about 10 % over that period.

Average annual core return on equity over a period is the ratio of: a) the sum of core income less preferred dividends for the periods presented to b) the sum of: 1) the sum of the adjusted average shareholders» equity for all full years in the period presented, and 2) for partial years in the period presented, the number of quarters in that partial year divided by four, multiplied by the adjusted average shareholders» equity of the partial year.

It also means that over the next year, Apple will be paying more back in dividends than any other publicly traded company, beating out oil giant Exxon Mobil for the position, according to Howard Siliverblatt, veteran market watcher and senior index analyst at S&P Dow Jones Indices.

Apple's long - term debt has grown to almost $ 100 billion over the past few years partly because it needs a source of funds to buy back stock and pay dividends.

That, combined with the demand for income from investors and the fact that companies have so much cash saved up, makes Iyer believe that over the next few years dividends will once again make up a significant part of the market's total return.

Next, we single out companies that have a history of growing their dividend over the past five years.

At the same time, the company has increased its dividend by 33 % over the past five years, yet its payout ratio is a paltry 9 %.

It has increased its dividend five times over the past five years.

With a 2 % dividend yield, we think the S&P 500 will reach 3500 over the next 10 years, implying annual price returns of 6 % per year.

The group chairman, Jose Vinals, said in the same statement that the board «understands the importance of the ordinary dividend to shareholders and intends to increase the full year dividend per share over time.»

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

The «Dividend Aristocrats» are a list of blue chip companies in the S&P 500 that have demonstrated a consistent increase in dividend payouts over thDividend Aristocrats» are a list of blue chip companies in the S&P 500 that have demonstrated a consistent increase in dividend payouts over thdividend payouts over the years.

We have about $ 650k in cash (which we use to buy & refurb small properties) the aforementioned $ 800k which is a nice mix of tech and F500 dividend payers, and just over $ 1M of retirement accounts - 750 in USA in appl, AMZN, GOOG etc, and $ 260K in UK where I worked for 12 years — BTW the $ 260K was $ 300K pre-Brexit.

But unless you got one heck of a deal, the delta in rent over dividends will have a very tough time making up for the 6 % per year difference in appreciation.

Over the years, I've built my own model to identify the best dividend paying companies.

-LSB-...] increasing its payout over the last seven years and is just three years away from making it to the Dividend Achievers list.

Dividend investors haven't necessarily had the easiest time finding good deals over the past few years.

This growth rate is the compound annual growth rate of cash dividends per common share of stock over the last 5 years.

I absolutely do not believe that mutual funds are a better investment than individual stocks (companies that pay rising dividends over time) over the long run, so I invest the rest of my savings in a taxable account (as well as maxing out my Roth IRA every year, of which individual stocks are purchased).

-LSB-...] a 10.58 % CAGR dividend growth rate over the past 5 years, AAPL is up to a great start to become a Dividend Achiever in no -dividend growth rate over the past 5 years, AAPL is up to a great start to become a Dividend Achiever in no -Dividend Achiever in no -LSB-...]

The bottom line with any investment is the quality of the firm's financial position, prospects for earnings growth over the next several years, dividend - growth potential, and the strength and defensibility of its industry position.

Instead, it looks for TSX - listed companies that have at least $ 300 mln in market cap and have paid and increased their dividends over each of the last five years.

The Minneapolis - based financial services company also announced a dividend of 90 cents per share, an 8 percent increase over the previous quarter and the 11th quarterly dividend increase in the last nine years.

It holds 60 companies, all of whom have consistently raised dividends over the last five years and have at least $ 300 mln in market cap, though the average is $ 8 billion.

We assess the value of dividends in various interest rate environments over an 88 - year period and discuss how to avoid typical «yield traps» in the design of high - dividend strategies.

Also, to be included in the Index, companies must have paid and increased thier dividends over each of the last five years.

Dividends on the Dow Jones Index are yielding about 2.6 %, a full half a percentage point over the 10 - year Treasury.

Apple has recently announced that it will return $ 100 billion to shareholders over three years through a combination of dividends and purchases of its own shares.

The lesson that valuations are important to long - term investment outcomes is underscored by the fact that the S&P 500 has lagged Treasury bills over the past 13 years, including dividends.

Per Figure 5, CLX has paid out cumulative dividends of $ 1.9 billion compared to cumulative cash flow of $ 3.3 billion over the past five years.

Over here, February is one of my worst months for dividends, but still managed to get about $ 16 worth, compared to last year's $ 1.40 I'm pretty happy with that.

The great news is that my dividend income has increase modestly over the past three years but is still far from my goal.

The company, which has a longstanding policy of paying out 70 - 80 % of its cash flow per share as dividends, returns over $ 5 billion to shareholders each year in the form of dividends.

Even though I'm still in the early stages here, it's amazing how quickly the dividend income has grown over the last year and a half through just regular contributions and reinvestment.

CSCO has increased its quarterly dividend from $ 0.14 to $ 0.29 over the past five years, or 16 % compounded annually.

I just consider myself lucky that I happened onto the dividend growth investing strategy fairly early when I decided to start investing in stocks and then the FI blogging community which I've learned so much from here over the last year.

As a dividend growth investor, you can look at several metrics to evaluate the performance of a stock over the last months, years or even decades.

Some analysts predict the company could send as much as $ 180 billion to investors through stock buybacks and dividend increases over the next two and a half years, on top of the $ 300 billion it has already authorized.

Hello fellow readers (if any of you are still left), it has been about half a year since I have posted and despite the lack content and blog growth I can assure you all my dividend income is still growing month over month.

Companies like Procter & Gamble, 3M, Emerson Electric, and Colgate - Palmolive have been raising dividends for over fifty years.

The dividend streaks are determined when the year is over, so it will show one year after December 31, 2015.

Over the last five years, Apple has returned $ 233 billion in cash to shareholders through buybacks and dividends.

I have been investing in Dividend Growth Stocks for over 2 years now and one thing that has not changed since I received my first distribution is the excitement I get whenever I count my dividends at the end of each month.

A value over 1.0 suggests that the dividend growth rate has been increasing as the 5 year rate is higher than the 10 year rate.

Over the past 5 years, BEP has maintained an 8 % FFO / units CAGR while increasing its dividends by 6 %.